O	0	4	Role	Role	NN	B-NP
O	5	7	of	of	IN	B-PP
O	8	20	thrombogenic	thrombogenic	JJ	B-NP
O	21	28	factors	factor	NNS	I-NP
O	29	31	in	in	IN	B-PP
O	32	35	the	the	DT	B-NP
O	36	47	development	development	NN	I-NP
O	48	50	of	of	IN	B-PP
O	51	66	atherosclerosis	atherosclerosis	NN	B-NP
O	66	67	.	.	.	O

O	68	78	Hemostatic	Hemostatic	JJ	B-NP
O	79	86	factors	factor	NNS	I-NP
O	87	91	play	play	VBP	B-VP
O	92	93	a	a	DT	B-NP
O	94	101	crucial	crucial	JJ	I-NP
O	102	106	role	role	NN	I-NP
O	107	109	in	in	IN	B-PP
O	110	120	generating	generate	VBG	B-VP
B-Pathological_formation	121	131	thrombotic	thrombotic	JJ	B-NP
I-Pathological_formation	132	137	plugs	plug	NNS	I-NP
O	138	140	at	at	IN	B-PP
B-Multi-tissue_structure	141	146	sites	site	NNS	B-NP
O	147	149	of	of	IN	B-PP
B-Multi-tissue_structure	150	158	vascular	vascular	JJ	B-NP
O	159	165	damage	damage	NN	I-NP
O	166	167	(	(	(	O
O	167	183	atherothrombosis	atherothrombosis	NN	B-NP
O	183	184	)	)	)	O
O	184	185	.	.	.	O

O	186	193	However	However	RB	B-ADVP
O	193	194	,	,	,	O
O	195	202	whether	whether	IN	B-SBAR
O	203	213	hemostatic	hemostatic	JJ	B-NP
O	214	221	factors	factor	NNS	I-NP
O	222	232	contribute	contribute	VBP	B-VP
O	233	241	directly	directly	RB	B-ADVP
O	242	244	or	or	CC	B-ADVP
O	245	255	indirectly	indirectly	RB	B-ADVP
O	256	258	to	to	TO	B-PP
O	259	262	the	the	DT	B-NP
O	263	275	pathogenesis	pathogenesis	NN	I-NP
O	276	278	of	of	IN	B-PP
O	279	294	atherosclerosis	atherosclerosis	NN	B-NP
O	295	302	remains	remain	VBZ	B-VP
O	303	312	uncertain	uncertain	JJ	B-ADJP
O	312	313	.	.	.	O

O	314	321	Autopsy	Autopsy	NN	B-NP
O	322	329	studies	study	NNS	I-NP
O	330	334	have	have	VBP	B-VP
O	335	343	revealed	reveal	VBN	I-VP
O	344	348	that	that	IN	B-SBAR
B-Tissue	349	356	intimal	intimal	JJ	B-NP
O	357	367	thickening	thickening	NN	I-NP
O	368	378	represents	represent	VBZ	B-VP
O	379	382	the	the	DT	B-NP
O	383	388	first	first	JJ	I-NP
O	389	394	stage	stage	NN	I-NP
O	395	397	of	of	IN	B-PP
O	398	413	atherosclerosis	atherosclerosis	NN	B-NP
O	414	417	and	and	CC	O
O	418	422	that	that	IN	B-SBAR
B-Pathological_formation	423	428	lipid	lipid	NN	B-NP
I-Pathological_formation	428	429	-	-	HYPH	B-NP
I-Pathological_formation	429	433	rich	rich	JJ	I-NP
I-Pathological_formation	434	440	plaque	plaque	NN	I-NP
O	441	447	arises	arise	VBZ	B-VP
O	448	452	from	from	IN	B-PP
O	453	457	such	such	JJ	B-NP
B-Pathological_formation	458	465	lesions	lesion	NNS	I-NP
O	465	466	.	.	.	O

O	467	474	Several	Several	JJ	B-NP
O	475	482	factors	factor	NNS	I-NP
O	483	493	contribute	contribute	VBP	B-VP
O	494	496	to	to	TO	B-PP
O	497	500	the	the	DT	B-NP
O	501	506	start	start	NN	I-NP
O	507	509	of	of	IN	B-PP
B-Tissue	510	517	intimal	intimal	JJ	B-NP
O	518	528	thickening	thickening	NN	I-NP
O	528	529	.	.	.	O

B-Cell	530	539	Platelets	Platelet	NNS	B-NP
O	540	547	release	release	VBP	B-VP
O	548	555	several	several	JJ	B-NP
O	556	562	growth	growth	NN	I-NP
O	563	570	factors	factor	NNS	I-NP
O	571	574	and	and	CC	O
O	575	584	bioactive	bioactive	JJ	B-NP
O	585	591	agents	agent	NNS	I-NP
O	592	596	that	that	WDT	B-NP
O	597	601	play	play	VBP	B-VP
O	602	603	a	a	DT	B-NP
O	604	611	central	central	JJ	I-NP
O	612	616	role	role	NN	I-NP
O	617	619	in	in	IN	B-PP
O	620	631	development	development	NN	B-NP
O	632	634	of	of	IN	B-PP
O	635	638	not	not	RB	B-CONJP
O	639	643	only	only	RB	I-CONJP
B-Pathological_formation	644	652	thrombus	thrombus	NN	B-NP
O	653	656	but	but	CC	B-CONJP
O	657	661	also	also	RB	I-CONJP
O	662	664	of	of	IN	B-PP
B-Tissue	665	672	intimal	intimal	JJ	B-NP
O	673	683	thickening	thickening	NN	I-NP
O	683	684	.	.	.	O

O	685	687	We	We	PRP	B-NP
O	688	692	have	have	VBP	B-VP
O	693	697	been	be	VBN	I-VP
O	698	711	investigating	investigate	VBG	I-VP
O	712	717	which	which	WDT	B-NP
O	718	729	coagulation	coagulation	NN	B-NP
O	730	737	factors	factor	NNS	I-NP
O	738	752	simultaneously	simultaneously	RB	B-ADVP
O	752	753	,	,	,	O
O	754	756	or	or	CC	O
O	757	769	subsequently	subsequently	RB	B-ADVP
O	770	774	with	with	IN	B-PP
B-Cell	775	783	platelet	platelet	NN	B-NP
O	784	795	aggregation	aggregation	NN	I-NP
O	795	796	,	,	,	O
O	797	808	participate	participate	VBP	B-VP
O	809	811	in	in	IN	B-PP
B-Pathological_formation	812	820	thrombus	thrombus	NN	B-NP
O	821	830	formation	formation	NN	I-NP
O	830	831	.	.	.	O

O	832	838	Tissue	Tissue	NN	B-NP
O	839	845	factor	factor	NN	I-NP
O	846	847	(	(	(	O
O	847	849	TF	TF	NN	B-NP
O	849	850	)	)	)	O
O	851	853	is	be	VBZ	B-VP
O	854	856	an	an	DT	B-NP
O	857	866	essential	essential	JJ	I-NP
O	867	876	initiator	initiator	NN	I-NP
O	877	879	of	of	IN	B-PP
B-Organism_substance	880	885	blood	blood	NN	B-NP
O	886	897	coagulation	coagulation	NN	I-NP
O	898	902	that	that	WDT	B-NP
O	903	905	is	be	VBZ	B-VP
O	906	915	expressed	express	VBN	I-VP
O	916	918	in	in	IN	B-PP
O	919	926	various	various	JJ	B-NP
O	927	933	stages	stage	NNS	I-NP
O	934	936	of	of	IN	B-PP
B-Pathological_formation	937	952	atherosclerotic	atherosclerotic	JJ	B-NP
I-Pathological_formation	953	960	lesions	lesion	NNS	I-NP
O	961	963	in	in	IN	B-PP
O	964	970	humans	human	NNS	B-NP
O	971	974	and	and	CC	O
O	975	980	other	other	JJ	B-NP
O	981	988	animals	animal	NNS	I-NP
O	988	989	.	.	.	O

O	990	997	Factors	Factor	NNS	B-NP
O	998	1007	including	include	VBG	B-PP
O	1008	1016	thrombin	thrombin	NN	B-NP
O	1017	1020	and	and	CC	I-NP
O	1021	1027	fibrin	fibrin	NN	I-NP
O	1027	1028	,	,	,	O
O	1029	1034	which	which	WDT	B-NP
O	1035	1038	are	be	VBP	B-VP
O	1039	1049	downstream	downstream	JJ	B-ADJP
O	1050	1052	of	of	IN	B-PP
O	1053	1056	the	the	DT	B-NP
O	1057	1068	coagulation	coagulation	NN	I-NP
O	1069	1076	cascade	cascade	NN	I-NP
O	1077	1086	activated	activate	VBN	B-VP
O	1087	1089	by	by	IN	B-PP
O	1090	1092	TF	TF	NN	B-NP
O	1092	1093	,	,	,	O
O	1094	1098	also	also	RB	B-ADVP
O	1099	1109	contribute	contribute	VBP	B-VP
O	1110	1112	to	to	TO	B-PP
O	1113	1128	atherosclerosis	atherosclerosis	NN	B-NP
O	1128	1129	.	.	.	O

O	1130	1132	TF	TF	NN	B-NP
O	1133	1135	is	be	VBZ	B-VP
O	1136	1144	involved	involve	VBN	I-VP
O	1145	1147	in	in	IN	B-PP
B-Cell	1148	1152	cell	cell	NN	B-NP
O	1153	1162	migration	migration	NN	I-NP
O	1162	1163	,	,	,	O
O	1164	1177	embryogenesis	embryogenesis	NN	B-NP
O	1178	1181	and	and	CC	I-NP
O	1182	1194	angiogenesis	angiogenesis	NN	I-NP
O	1194	1195	.	.	.	O

O	1196	1200	Thus	Thus	RB	B-NP
O	1201	1203	TF	TF	NN	I-NP
O	1203	1204	,	,	,	O
O	1205	1207	in	in	IN	B-PP
O	1208	1216	addition	addition	NN	B-NP
O	1217	1219	to	to	TO	B-PP
O	1220	1227	factors	factor	NNS	B-NP
O	1228	1238	downstream	downstream	RB	B-ADVP
O	1239	1241	of	of	IN	B-PP
O	1242	1245	the	the	DT	B-NP
O	1246	1257	coagulation	coagulation	NN	I-NP
O	1258	1265	cascade	cascade	NN	I-NP
O	1266	1269	and	and	CC	O
O	1270	1273	the	the	DT	B-NP
O	1274	1282	protease	protease	NN	I-NP
O	1282	1283	-	-	HYPH	O
O	1283	1292	activated	activate	VBN	B-VP
O	1293	1301	receptor	receptor	NN	B-NP
O	1302	1303	2	2	CD	I-NP
O	1304	1314	activation	activation	NN	I-NP
O	1315	1321	system	system	NN	I-NP
O	1321	1322	,	,	,	O
O	1323	1328	would	would	MD	B-VP
O	1329	1331	be	be	VB	I-VP
O	1332	1333	a	a	DT	B-NP
O	1334	1348	multifactorial	multifactorial	JJ	I-NP
O	1349	1358	regulator	regulator	NN	I-NP
O	1359	1361	of	of	IN	B-PP
O	1362	1375	atherogenesis	atherogenesis	NN	B-NP
O	1375	1376	.	.	.	O

